Lilly completes offer for ImClone
This article was originally published in Scrip
Executive Summary
Lillyhas completed its tender offer for all of ImClone Systems's outstanding shares.. The $70 per share cash offer, conducted through Lilly's subsidiary Alaska Acquisition, expired at midnight EST on November 20th. Around 85.4 million shares were tendered, representing 95.5% of ImClone's issued and outstanding shares. Lilly plans to complete the acquisition through a short-form merger on or by Monday. All outstanding shares of ImClone's common stock not already purchased by Alaska will be converted into the right to receive $70 per share in cash. The offer's completion marks the end of one of this year's most headline-grabbing takeover stories after Bristol-Myers Squibbfailed to acquire ImClone. Lilly subsequently emerged as a mystery bidder and succeeded in offering what chairman Carl Icahn believed was an acceptable bid (Scrip Online, October 7th, 2008).
You may also be interested in...
Myotec and Hybrid merge to form PsiOxus
Myotec Therapeutics and Hybrid Biosystems are to merge to form PsiOxus Therapeutics with £3.6 million in funding from a syndicate led by the former's previous backer Imperial Innovations.
Trophos's MitoCare programme receives €6 million EU funding
A Phase II efficacy and safety study of Trophos' cholesterol-oxime compound TRO40303 to treat cardiac ischaemia-reperfusion injury in acute myocardial infarction patients will be substantially underwritten by funds from the European Union, the Marseilles-based company says. Trophos is to head a new 16-partner consortium called MitoCare, a 2.5 year international translational medicine project that has received a €6 million award under the European Union Seventh Framework Programme for research. The project will begin in January 2011.
Novartis and Alcon reach compromise to settle merger saga
Alcon's board of directors has finally approved a merger agreement with Novartis for the Alcon shares the latter does not already own, drawing a close to protracted negotiations that first began nearly a year ago.